FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Buolamwini

Research Profile

Chemicals & Drugs

Concepts & Ideas

Occupations

Drug Design

Genes & Molecular Sequences

Molecular Structure

Anatomy

Co-author Network

Publications

TOP 3
Chunmei Wang; Meiyun Fan; Luciana P Schwab; Tiffany N. Seagroves; John K Buolamwini
Chemoprevention Activity of Dipyridamole in the MMTV-PyMT Transgenic Mouse Model of Breast Cancer.
Chunwan Lu; Chunhong Yan; Xiaoming Yu; Yi Zhang; John K Buolamwini; Hemantkumar Deokar; Jing Jin; Di Liu; Xiaoguang Chen
Inhibition of gastric tumor growth by a novel Hsp90 inhibitor.
Horrick Sharma; Xiaolin Cheng; John K Buolamwini
Homology model-guided 3D-QSAR studies of HIV-1 integrase inhibitors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Buolamwini (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Chunmei Wang; Meiyun Fan; Luciana P Schwab; Tiffany N. Seagroves; John K Buolamwini
Chemoprevention Activity of Dipyridamole in the MMTV-PyMT Transgenic Mouse Model of Breast Cancer.
Cancer prevention research (Philadelphia, Pa.) 2013;6(5):437-47.
2013: Chunwan Lu; Chunhong Yan; Xiaoming Yu; Yi Zhang; John K Buolamwini; Hemantkumar Deokar; Jing Jin; Di Liu; Xiaoguang Chen
Inhibition of gastric tumor growth by a novel Hsp90 inhibitor.
Biochemical pharmacology 2013;85(9):1246-56.
2012: Horrick Sharma; Xiaolin Cheng; John K Buolamwini
Homology model-guided 3D-QSAR studies of HIV-1 integrase inhibitors.
Journal of chemical information and modeling 2012;52(2):515-44.
2012: Xinyi Yang; John K Buolamwini; Jiang-Jiang Qin; Horrick Sharma; Hui Wang; Ming-Hai Wang; Wei Wang; Ruiwen Zhang
JKA97, a novel benzylidene analog of harmine, exerts anti-cancer effects by inducing G1 arrest, apoptosis, and p53-independent up-regulation of p21.
PloS one 2012;7(4):e34303.
2011: Wenwei Lin; John K Buolamwini
Design, synthesis, and evaluation of 2-diethanolamino-4,8-diheptamethyleneimino-2-(N-aminoethyl-N-ethanolamino)-6-(N,N-diethanolamino)pyrimido[5,4-d]pyrimidine-fluorescein conjugate (8MDP-fluor), as a novel equilibrative nucleoside transporter probe.
Bioconjugate chemistry 2011;22(6):1221-7.
2011: Horrick Sharma; Shivaputra Patil; Tino W Sanchez; Nouri Neamati; Ray F Schinazi; John K Buolamwini
Synthesis, biological evaluation and 3D-QSAR studies of 3-keto salicylic acid chalcones and related amides as novel HIV-1 integrase inhibitors.
Bioorganic & medicinal chemistry 2011;19(6):2030-45.
2011: Hongbo Wang; Xujun Ma; Shumei Ren; John K Buolamwini; Chunhong Yan
A small-molecule inhibitor of MDMX activates p53 and induces apoptosis.
Molecular cancer therapeutics 2011;10(1):69-79.
2010: Brent J Passer; Tooba Cheema; Bingsen Zhou; Hiroaki Wakimoto; Cecile Zaupa; Mani Razmjoo; Jason Sarte; Shulin Wu; Chin-Lee Wu; James W Noah; Qianjun Li; John K Buolamwini; Yun Yen; Samuel D Rabkin; Robert L Martuza
Identification of the ENT1 antagonists dipyridamole and dilazep as amplifiers of oncolytic herpes simplex virus-1 replication.
Cancer research 2010;70(10):3890-5.
2010: Chunmei Wang; Surekha Pimple; John K Buolamwini
Interaction of benzopyranone derivatives and related compounds with human concentrative nucleoside transporters 1, 2 and 3 heterologously expressed in porcine PK15 nucleoside transporter deficient cells. Structure-activity relationships and determinants of transporter affinity and selectivity.
Biochemical pharmacology 2010;79(3):307-20.
2009: Amol Gupte; John K Buolamwini
Synthesis and biological evaluation of phloridzin analogs as human concentrative nucleoside transporter 3 (hCNT3) inhibitors.
Bioorganic & medicinal chemistry letters 2009;19(3):917-21.
2009: Amol Gupte; John K Buolamwini
CoMFA and CoMSIA 3D-QSAR studies on S(6)-(4-nitrobenzyl)mercaptopurine riboside (NBMPR) analogs as inhibitors of human equilibrative nucleoside transporter 1 (hENT1).
Bioorganic & medicinal chemistry letters 2009;19(2):314-8.
2008: Kirk Edward Hevener; David M Ball; John K Buolamwini; Richard E Lee
Quantitative structure-activity relationship studies on nitrofuranyl anti-tubercular agents.
Bioorganic & medicinal chemistry 2008;16(17):8042-53.
2008: Zhengxiang Zhu; John K Buolamwini
Constrained NBMPR analogue synthesis, pharmacophore mapping and 3D-QSAR modeling of equilibrative nucleoside transporter 1 (ENT1) inhibitory activity.
Bioorganic & medicinal chemistry 2008;16(7):3848-65.
2008: Wenjing Luo; Jinyi Liu; Jingxia Li; Dongyun Zhang; Mingchao Liu; James K Addo; Shivaputra Patil; Lin Zhang; Jian Yu; John K Buolamwini; Jingyuan Chen; Chuanshu Huang
Anti-cancer effects of JKA97 are associated with its induction of cell apoptosis via a Bax-dependent and p53-independent pathway.
The Journal of biological chemistry 2008;283(13):8624-33.
2007: Amol Gupte; John K Buolamwini
Novel C2-purine position analogs of nitrobenzylmercaptopurine riboside as human equilibrative nucleoside transporter 1 inhibitors.
Bioorganic & medicinal chemistry 2007;15(24):7726-37.
2007: Wenwei Lin; John K Buolamwini
Synthesis, flow cytometric evaluation, and identification of highly potent dipyridamole analogues as equilibrative nucleoside transporter 1 inhibitors.
Journal of medicinal chemistry 2007;50(16):3906-20.
2007: Z Zhu; Polly A Hofmann; John K Buolamwini
Cardioprotective effects of novel tetrahydroisoquinoline analogs of nitrobenzylmercaptopurine riboside in an isolated perfused rat heart model of acute myocardial infarction.
American journal of physiology. Heart and circulatory physiology 2007;292(6):H2921-6.
2007: Shivaputra Patil; Shantaram Kamath; Tino Sanchez; Nouri Neamati; Ray F Schinazi; John K Buolamwini
Synthesis and biological evaluation of novel 5(H)-phenanthridin-6-ones, 5(H)-phenanthridin-6-one diketo acid, and polycyclic aromatic diketo acid analogs as new HIV-1 integrase inhibitors.
Bioorganic & medicinal chemistry 2007;15(3):1212-28.
2006: Shantaram Kamath; John K Buolamwini
Targeting EGFR and HER-2 receptor tyrosine kinases for cancer drug discovery and development.
Medicinal research reviews 2006;26(5):569-94.
2005: Amol Gupte; John K Buolamwini; Vikas Yadav; Chung (David) K. Chu; Fardos N M Naguib; Mahmoud el Kouni
6-Benzylthioinosine analogues: promising anti-toxoplasmic agents as inhibitors of the mammalian nucleoside transporter ENT1 (es).
Biochemical pharmacology 2005;71(1-2):69-73.
2005: John K Buolamwini; Shantaram Kamath
Molecule-kinase interaction map.
Nature biotechnology 2005;23(11):1346; author reply 1346-8.
2005: Kuntebommanahalli N Thimmaiah; John B Easton; Glen S Germain; Christopher L Morton; Shantaram Kamath; John K Buolamwini; Peter J Houghton
Identification of N10-substituted phenoxazines as potent and specific inhibitors of Akt signaling.
The Journal of biological chemistry 2005;280(36):31924-35.
2005: Shantaram A Kamath; John K Buolamwini
Asp746 to glycine change may have a greater influence than Cys751 to serine change in accounting for ligand selectivity between EGFR and HER-2 at the ATP site.
Journal of computer-aided molecular design 2005;19(5):287-91.
2005: John K Buolamwini; James Addo; Shantaram Kamath; Shivaputra Patil; Darius Mason; Marian Ores
Small molecule antagonists of the MDM2 oncoprotein as anticancer agents.
Current cancer drug targets 2005;5(1):57-68.
2004: Amol Gupte; John K Buolamwini
Novel halogenated nitrobenzylthioinosine analogs as es nucleoside transporter inhibitors.
Bioorganic & medicinal chemistry letters 2004;14(9):2257-60.
2004: James K Addo; John K Buolamwini
Design, synthesis, and evaluation of 5'-S-aminoethyl-N(6)- azidobenzyl-5'-thioadenosine biotin conjugate: a bifunctional photoaffinity probe for the es nucleoside transporter.
Bioconjugate chemistry 2004;15(3):536-40.
2004: Chih-Ling Kuo; Haregewein Assefa; Shantaram Kamath; Zdzislaw Brzozowski; Jaroslaw Slawinski; Franciszek Saczewski; John K Buolamwini; Nouri Neamati
Application of CoMFA and CoMSIA 3D-QSAR and docking studies in optimization of mercaptobenzenesulfonamides as HIV-1 integrase inhibitors.
Journal of medicinal chemistry 2004;47(2):385-99.
2003: Shantaram Kamath; John K Buolamwini
Receptor-guided alignment-based comparative 3D-QSAR studies of benzylidene malonitrile tyrphostins as EGFR and HER-2 kinase inhibitors.
Journal of medicinal chemistry 2003;46(22):4657-68.
2003: Haregewein Assefa; Shantaram Kamath; John K Buolamwini
3D-QSAR and docking studies on 4-anilinoquinazoline and 4-anilinoquinoline epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors.
Journal of computer-aided molecular design 2003;17(8):475-93.
2003: Zhengxiang Zhu; John Furr; John K Buolamwini
Synthesis and flow cytometric evaluation of novel 1,2,3,4-tetrahydroisoquinoline conformationally constrained analogues of nitrobenzylmercaptopurine riboside (NBMPR) designed for probing its conformation when bound to the es nucleoside transporter.
Journal of medicinal chemistry 2003;46(5):831-7.
2003: John K Buolamwini; Haregewein Assefa
Overview of novel anticancer drug targets.
Methods in molecular medicine 2003;85():3-28.
2002: John K Buolamwini; Haregewein Assefa
CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site.
Journal of medicinal chemistry 2002;45(4):841-52.